# MBOT (Microbot Medical Inc.) - SEC EDGAR Financial Statements

> Microbot Medical Inc. reported $68.21M in total assets and a net loss of $18.60M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MBOT
- Markdown: https://convexityos.com/fundamentals/MBOT.md
- SEC CIK: 0000883975
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:51 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000883975&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$21.14M | Operating profit |
| Net Income | FY 2025 | -$18.60M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.28 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$19.60M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $61.83M | Total debt: $838K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $6.28M | $6.63M | $5.72M | $7.74M | $6.15M | $3.40M | $3.05M | $2.52M | $1.10M | -$901K |
| Selling, General & Admin | $8.46M | $5.00M | -- | -- | -- | -- | -- | -- | -- | -- |
| **Operating Income** | -$14.74M | -$11.62M | -$9.86M | -$13.28M | -$11.36M | -$9.09M | -$7.24M | -$7.24M | $5.27M | -$9.63M |
| **EBITDA** | -$14.70M | -$11.53M | -$9.75M | -$13.18M | -$11.28M | -$9.02M | -$7.16M | -$7.19M | $5.29M | -$9.62M |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | $237K | $333K |
| Income Tax Expense | -- | -- | -- | -- | -- | $0 | $0 | -- | -- | -- |
| **Net Income** | -$13.14M | -$11.44M | -$10.74M | -$13.17M | -$11.31M | -$9.17M | -$7.25M | -$7.26M | -$7.59M | -$9.66M |
| Basic EPS | -$0.29 | -$0.73 | -$1.05 | -$1.81 | -$1.59 | -$1.29 | -$1.70 | -$2.41 | -$2.76 | $0.40 |
| **Diluted EPS** | -$0.29 | -$0.73 | -$1.05 | -$1.81 | -$1.59 | -$1.29 | -$1.70 | -$2.41 | -$2.76 | $0.40 |
| Basic Shares Outstanding | 45.8M | 15.6M | 10.2M | 7.3M | 7.1M | 7.1M | 4.3M | 2.9M | 2.2M | 14.3M |
| Diluted Shares Outstanding | 45.8M | 15.6M | 10.2M | 7.3M | 7.1M | 7.1M | 4.3M | 2.9M | 2.2M | 14.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $72K | $241K | $105K | -- | -- | -- | -- | -- |
| Cost of Revenue | $1.09M | $884K | $103K | -- | -- | -- | -- | -- |
| **Gross Profit** | -$1.02M | -$643K | $2.0K | -- | -- | -- | -- | -- |
| Research & Development | $1.63M | $1.86M | $1.29M | $1.54M | $1.17M | $2.11M | $1.46M | $1.98M |
| Selling, General & Admin | $1.84M | $3.68M | $3.03M | $3.13M | $2.16M | $1.61M | $1.56M | -- |
| **Operating Income** | -$6.49M | -$6.19M | -$4.32M | -$4.14M | -$3.86M | -$3.72M | -$3.02M | -$3.43M |
| **EBITDA** | -$6.47M | -$6.17M | -$4.31M | -$4.13M | -$3.85M | -$3.71M | -$3.01M | -$3.40M |
| **Net Income** | -$5.84M | -$5.63M | -$3.67M | -$3.46M | -$3.58M | -$3.50M | -$2.60M | -$3.39M |
| Basic EPS | -$0.09 | -$0.08 | -$0.05 | -- | -$0.07 | -$0.10 | -$0.08 | -- |
| **Diluted EPS** | -$0.09 | -$0.08 | -$0.05 | -- | -$0.07 | -$0.10 | -$0.08 | -- |
| Basic Shares Outstanding | 67.2M | 67.2M | 67.2M | -- | 48.1M | 36.5M | 31.1M | -- |
| Diluted Shares Outstanding | 67.2M | 67.2M | 67.2M | -- | 48.1M | 36.5M | 31.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.91M | $3.11M | $2.47M | $2.44M | $13.49M | $19.65M | $28.77M | $5.24M | $10.79M | $2.71M |
| Short-Term Investments | $74.68M | $2.36M | $3.92M | $5.76M | $2.00M | $5.00M | $2.52M | -- | -- | -- |
| **Cash & Short-Term Investments** | $78.59M | $5.47M | $6.38M | $8.20M | $15.49M | $24.65M | $31.29M | $5.24M | $10.79M | $2.71M |
| Inventory | $584K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | $1.33M | -- | $300K | $521K | $286K | $568K | $116K | $606K |
| **Total Current Assets** | $79.82M | $5.82M | $7.92M | $8.81M | $15.88M | $25.25M | $35.94M | $5.83M | $10.93M | $3.31M |
| Property, Plant & Equipment, Net | $93K | $80K | $146K | $221K | $244K | $251K | $228K | $259K | $90K | $53K |
| **Total Non-Current Assets** | $1.72M | $212K | $406K | $723K | $888K | $1.03M | $1.19M | $259K | $90K | $53K |
| **Total Assets** | $81.54M | $6.03M | $8.33M | $9.54M | $16.77M | $26.28M | $37.13M | $6.09M | $11.02M | $3.37M |
| Accounts Payable | $511K | $165K | $357K | $116K | $279K | $275K | $284K | $630K | $78K | $512K |
| Other Current Liabilities | $5.0K | $5.0K | $79K | -- | -- | -- | $608K | $468K | $330K | $145K |
| **Total Current Liabilities** | $3.42M | $2.46M | $3.79M | $2.07M | $1.98M | $1.34M | $4.83M | $4.76M | $528K | $783K |
| **Total Non-Current Liabilities** | $569K | $41K | $40K | $179K | $402K | $626K | $760K | $8.0K | $28K | $389K |
| **Total Liabilities** | $3.99M | $2.50M | $3.83M | $2.25M | $2.39M | $1.97M | $5.59M | $4.76M | $556K | $1.17M |
| **Total Debt (incl. Leases)** | $865K | $111K | $231K | $462K | $680K | $813K | $903K | -- | -- | -- |
| Common Stock | $672K | $195K | $118K | $80K | $72K | $72K | $72K | $31K | $27K | $266K |
| Retained Earnings | -$104.1M | -$90.94M | -$79.50M | -$68.76M | -$55.59M | -$44.28M | -$35.11M | -$27.86M | -$20.62M | -$13.04M |
| **Total Stockholders' Equity** | $77.55M | $3.53M | $4.50M | $7.29M | $14.38M | $24.31M | $31.54M | $1.33M | $9.99M | $1.70M |
| Total Equity | $77.55M | $3.53M | $4.50M | $7.29M | $14.38M | $24.31M | $31.54M | $1.33M | $9.99M | $1.70M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.29M | $3.15M | $3.66M | $3.91M | $6.70M | $4.08M | $3.22M | $3.11M |
| Short-Term Investments | $59.54M | $64.22M | $68.84M | $74.68M | $73.45M | $28.59M | $27.17M | $2.36M |
| **Cash & Short-Term Investments** | $61.83M | $67.37M | $72.50M | $78.59M | $80.16M | $32.67M | $30.39M | $5.47M |
| Accounts Receivable, Net | $90K | $176K | $105K | -- | -- | -- | -- | -- |
| Inventory | $3.21M | $2.91M | $2.26M | $584K | -- | -- | -- | -- |
| **Total Current Assets** | $66.87M | $72.17M | $76.53M | $79.82M | $80.78M | $32.89M | $30.66M | $5.82M |
| Property, Plant & Equipment, Net | $486K | $316K | $188K | $93K | $78K | $75K | $78K | $80K |
| **Total Non-Current Assets** | $1.34M | $1.19M | $1.54M | $1.72M | $975K | $240K | $236K | $212K |
| **Total Assets** | $68.21M | $73.36M | $78.07M | $81.54M | $81.76M | $33.13M | $30.89M | $6.03M |
| Accounts Payable | $857K | $871K | $1.08M | $511K | $509K | $503K | $186K | $165K |
| Other Current Liabilities | -- | -- | -- | $5.0K | -- | -- | -- | $5.0K |
| **Total Current Liabilities** | $4.26M | $3.89M | $3.39M | $3.42M | $2.93M | $2.73M | $1.89M | $2.46M |
| **Total Non-Current Liabilities** | $504K | $550K | $574K | $569K | $602K | $47K | $48K | $41K |
| **Total Liabilities** | $4.76M | $4.44M | $3.96M | $3.99M | $3.54M | $2.77M | $1.94M | $2.50M |
| **Total Debt (incl. Leases)** | $838K | $876K | $898K | $865K | $899K | $149K | $138K | $111K |
| Common Stock | $672K | $672K | $672K | $672K | $659K | $380K | $348K | $195K |
| Retained Earnings | -$119.2M | -$113.4M | -$107.8M | -$104.1M | -$100.6M | -$97.05M | -$93.55M | -$90.94M |
| **Total Stockholders' Equity** | $63.45M | $68.93M | $74.11M | $77.55M | $78.22M | $30.36M | $28.95M | $3.53M |
| Total Equity | $63.45M | $68.93M | $74.11M | $77.55M | $78.22M | $30.36M | $28.95M | $3.53M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$13.14M | -$11.44M | -$10.74M | -$13.17M | -$11.31M | -$9.17M | $7.25M | $7.26M | $7.59M | $9.66M |
| Depreciation & Amortization | $47K | $91K | $106K | $102K | $76K | $68K | $84K | $54K | $21K | $10K |
| Stock-Based Compensation | $1.06M | $1.35M | $1.39M | $1.75M | $1.39M | $1.94M | $1.10M | $1.40M | $479K | $676K |
| Change in Inventory | -$584K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$13.05M | -$8.83M | -$8.53M | -$11.55M | -$9.35M | -$7.25M | -$6.45M | -$5.31M | -$4.86M | -$786K |
| Capital Expenditure | -$60K | -$25K | -$33K | -$84K | -$69K | -$91K | -$216K | -$223K | -$58K | -$25K |
| **Free Cash Flow** | -$13.11M | -$8.85M | -$8.57M | -$11.63M | -$9.42M | -$7.34M | -$6.67M | -$5.53M | -$4.91M | -$811K |
| Purchases of Investments | -- | -- | -$10.06M | -$3.75M | -- | -$5.00M | -$2.50M | -- | -- | -- |
| Sales & Maturities of Investments | -- | -- | -- | -- | $270K | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$72.38M | $1.54M | $1.97M | -$3.84M | $3.20M | -$2.77M | -$2.45M | -$223K | -$58K | -$25K |
| Common Stock Issued | $86.24M | $7.94M | $6.56M | $4.32M | -- | -- | $36.77M | -- | $12.70M | -- |
| **Financing Cash Flow** | $86.24M | $7.94M | $6.56M | $4.32M | -- | -$3.38M | $36.77M | -$18K | $13.02M | $3.08M |
| **Net Change in Cash** | $810K | $646K | -$2.0K | -$11.06M | -$6.15M | -$13.39M | $27.87M | -$5.55M | $8.11M | $2.27M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.84M | -$5.63M | -$3.67M | -$3.46M | -$3.58M | -$3.50M | -$2.60M | -$3.39M |
| Depreciation & Amortization | $28K | $15K | $12K | $10K | $10K | $12K | $15K | $26K |
| Stock-Based Compensation | $362K | $433K | $222K | $236K | $328K | $237K | $256K | $282K |
| Change in Receivables | $86K | -$71K | -$105K | -- | -- | -- | -- | -- |
| Change in Inventory | -$306K | -$650K | -$1.67M | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$5.41M | -$4.99M | -$5.05M | -$3.76M | -$3.84M | -$2.57M | -$2.87M | -$1.69M |
| Capital Expenditure | -$115K | -$142K | -$108K | -$25K | -$13K | -$9.0K | -$13K | -$7.0K |
| **Free Cash Flow** | -$5.52M | -$5.13M | -$5.16M | -$3.78M | -$3.85M | -$2.58M | -$2.89M | -$1.70M |
| Purchases of Investments | -$582K | -$629K | -$441K | -- | -$48.00M | -$3.80M | -$28.12M | -- |
| **Investing Cash Flow** | $4.55M | $4.47M | $5.00M | -$1.53M | -$44.71M | -$1.31M | -$24.83M | $1.50M |
| Common Stock Issued | -- | -- | -- | $2.51M | $51.17M | $4.75M | $27.81M | $2.83M |
| **Financing Cash Flow** | -- | -- | -- | $2.51M | $51.18M | $4.75M | $27.81M | $2.83M |
| **Net Change in Cash** | -$861K | -$502K | -$56K | -$2.79M | $2.62M | $870K | $102K | $2.64M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -16.9% | -324.2% | -238.6% | -180.7% | -78.7% | -37.7% | -23.0% | -545.9% | -76.0% | -569.8% |
| Return on Assets (ROA) | -16.1% | -189.7% | -129.0% | -138.1% | -67.5% | -34.9% | -19.5% | -119.2% | -68.9% | -286.9% |
| Current Ratio | 23.33x | 2.37x | 2.09x | 4.26x | 8.00x | 18.78x | 7.45x | 1.23x | 20.70x | 4.23x |
| Quick Ratio | 23.16x | 2.22x | 1.69x | 3.96x | 7.81x | 18.33x | 6.48x | 1.10x | 20.43x | 3.46x |
| Debt to Equity | 0.01x | 0.03x | 0.05x | 0.06x | 0.05x | 0.03x | 0.03x | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -237.5% | -- | -1153.0% |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -790.0% | +900.0% |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -29.3% | -23.7% | -19.2% | -16.9% | -16.7% | -41.9% | -40.3% | -324.2% |
| Return on Assets (ROA) | -27.3% | -22.3% | -18.2% | -16.1% | -16.0% | -38.4% | -37.8% | -189.7% |
| Current Ratio | 15.70x | 18.56x | 22.59x | 23.33x | 27.53x | 12.06x | 16.19x | 2.37x |
| Quick Ratio | 14.94x | 17.82x | 21.93x | 23.16x | 27.32x | 11.98x | 16.05x | 2.22x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.03x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
